[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334755-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334755-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metochalcone-induces-senescence-associated-secretory-phenotype-via-jak2stat3-pathway-in-breast-cancer","Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer","","Breast and lung cancers drive high mortality and frequent diagnoses worldwide. Although chalcone antitumor activity has been studied, the molecular mechanisms of the isoliquiritigenin analog 2',4',4-trihydroxychalcone (metochalcone; TEC) against carcinomas are less clear. TEC suppresses proliferation of BT549 and A549 cells, arrests the S-phase, inhibits migration, and reduces tumor growth in vivo. Transcriptomics links TEC to JAK2/STAT3 and P53 pathway modulation, with SASP induction via JAK2/STAT3 repression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metochalcone-induces-senescence-associated-secretory-phenotype-via-jak2stat3-pathway-in-breast-cancer/334755/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metochalcone-induces-senescence-associated-secretory-phenotype-via-jak2stat3-pathway-in-breast-cancer/334755.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is metochalcone (TEC) and why is it studied in breast cancer?","Question",{"text":63,"@type":64},"Metochalcone (TEC) is a chalcone-related compound studied for its anticancer effects. The research focuses on its molecular actions in breast cancer and the broader carcinomas context.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does TEC affect breast and lung cancer cells in vitro and in vivo?",{"text":68,"@type":64},"TEC inhibits proliferation of BT549 (breast) and A549 (lung) cells in a concentration-dependent manner, induces S-phase cell cycle arrest, suppresses cell migration in vitro, and reduces tumor growth in vivo.",{"name":70,"@type":61,"acceptedAnswer":71},"Which signaling pathway is central to TEC’s induction of SASP?",{"text":72,"@type":64},"The study concludes that TEC triggers the senescence-associated secretory phenotype (SASP) by repressing the JAK2/STAT3 axis, linking pathway deactivation to SASP induction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334755,1791022724,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","ONCOLOGY RESEARCH 2024 32(5): 943-953  \nMetochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer  \nJIANBO ZHOU 1,2,3; FENG WAN2,4; BIN XIAO5; XIN LI 1; CHENG PENG2,*; FU PENG 1,3,*  \n1 Department of Pharmacology, West China School of Pharmacy, Sichuan University, Chengdu, China  \n2 State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China  \n3 Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, Sichuan University, Chengdu, China  \n4 Chengdu No. 1 Pharmaceutical Co., Ltd., Pengzhou, China  \n5 Chengdu Push Bio-Technology Co., Ltd., Chengdu, China  \nKey words: Metochalcone, Breast cancer, Lung cancer, SASP, JAK2/STAT3  \nAbstract: Breast and lung cancers are the leading causes of mortality and most frequently diagnosed cancers in women and men, respectively, worldwide. Although the antitumor activity of chalcones has been extensively studied, the molecular mechanisms of isoliquiritigenin analog 2', 4', 4-trihydroxychalcone (metochalcone; TEC) against carcinomas remain less well understood. In this study, we found that TEC inhibited cell proliferation of breast cancer BT549 cells and lung cancer A549 cells in a concentration-dependent manner. TEC induced cell cycle arrest in the S-phase, cell migration inhibition in vitro, and reduced tumor growth in vivo. Moreover, transcriptomic analysis revealed that TEC modulated the activity of the JAK2/STAT3 and P53 pathways. TEC triggered the senescence-associated secretory phenotype (SASP) by repressing the JAK2/STAT3 axis. The mechanism of metochalcone against breast cancer depended on the induction of SASP via deactivation of the JAK2/STAT3 pathway, highlighting the potential of  \nchalcone in senescence-inducing therapy against carcinomas.  \nIntroduction  \nBreast and lung cancers have the highest mortality and diagnosis rates in women and men, respectively [1,2] . Traditional Chinese medicine and ethnopharmacology have considerable potential as molecular libraries for screening small molecules against cancers [3] . Although traditional Chinese medicine is considered a complementary and alternative treatment for cancer treatment [4], Caulis Spatholobi (the stem of Spatholobus suberectus Dunn), a traditional Chinese medicine to potentialize blood circulation and eliminate stasis [5], remains poorly understood. The efﬁcacy of Caulis Spatholobi against tumor metastasis in colorectal and breast cancers has been demonstrated through alleviating tumor cell-induced platelet aggregation and reshaping epithelial-mesenchymal transition in preclinical studies [6,7] . Several ﬂavonoids, including  \n*Address correspondence to: Cheng Peng,  \n[pengchengchengdu@126.com](pengchengchengdu@126.com); Fu Peng, [fujing126@yeah.net](fujing126@yeah.net)  \n[Received: 08 August 2023](Received: 08 August 2023); [Accepted: 24 November 2023](Accepted: 24 November 2023);  \nPublished: 23 April 2024  \nDoi: 10.32604/or.2023.044775  \nchalcones, have been identiﬁed as the bioactive components in Caulis Spatholobi [8] . In a previous study on Spatholobus suberectus Dunn, we reported the anti-proliferative properties of 2', 4, 4'-trimethoxychalcone (TEC, Fig. 1A) or metochalcone against breast cancer [9] .  \nCellular senescence is a common and inevitable physiological process in cells, including cancer cells, featured by cell cycle arrest, an increase in senescence-associated β -galactosidase, structural and metabolic changes, and so on [10] . The senescence-associated secretory phenotype (SASP) has all the hallmarks of cell senescence and is characterized by the numerous secretions of pro-inﬂammatory cytokines, growth factors, and so forth. SASP is initiated by several signaling pathways, mainly NF-κB, CEBPβ, JAK/STAT, p38 MAPK37 and mTOR, etc [11] . Tar","cbCaisUaNKBfFNgK","https://ap.wps.com/l/cbCaisUaNKBfFNgK","pdf",18521102,11,"English","# Introduction\n## Cellular senescence and SASP\n## JAK2/STAT3 in cancer\n# Materials and Methods\n## Cell culture and cell viability assay","[{\"question\":\"What is metochalcone (TEC) and why is it studied in breast cancer?\",\"answer\":\"Metochalcone (TEC) is a chalcone-related compound studied for its anticancer effects. The research focuses on its molecular actions in breast cancer and the broader carcinomas context.\"},{\"question\":\"How does TEC affect breast and lung cancer cells in vitro and in vivo?\",\"answer\":\"TEC inhibits proliferation of BT549 (breast) and A549 (lung) cells in a concentration-dependent manner, induces S-phase cell cycle arrest, suppresses cell migration in vitro, and reduces tumor growth in vivo.\"},{\"question\":\"Which signaling pathway is central to TEC’s induction of SASP?\",\"answer\":\"The study concludes that TEC triggers the senescence-associated secretory phenotype (SASP) by repressing the JAK2/STAT3 axis, linking pathway deactivation to SASP induction.\"}]","Metochalcone induces senescence-associated secretory phenotype via JAK2/STAT3 pathway in breast cancer | PDF",1790008194,28]